The blocking effect of BMP inhibitor on the emergence of immunosuppressive γδ T subset in our study, along with previous reports showing that BMP inhibitors blocked the BMPs-induced oncogenes expression in AML cells (25, 26), highlights the application significance of BMP inhibitors in the treatment of hematopoietic malignancies. The gene discussed is CLN5; the disease is acute myeloid leukemia.